Henrik Johansen

Kings College London Anti-MAP Vaccine Donation

Fundraising for King's College London
£125
raised of £1,000 target
by 3 supporters
Donations cannot currently be made to this page
King's College London

Verified by JustGiving

RCN Exempt Charities Act 1993

Story

OUR MISSION: To Cure Crohn’s Disease



We believe the Crohn’s MAP Vaccine currently is the best hope of curing Crohn’s disease. This is based on over 30 years of research, hundreds of scientific papers and the contribution of scientists from all round the globe.



The Crohn’s MAP Vaccine team came together to support the ground-breaking work of Prof. John Hermon-Taylor. It comprises Dr Amy Hermon-Taylor (Prof. Hermon-Taylor’s daughter) and a large group of volunteers all of whom are directly affected by Crohn’s disease.



Our key objectives:


To provide a comprehensive resource on the role of MAP in Crohn’s Disease


To provide the latest information about progress on the Crohn’s MAP Vaccine and MAP Test


To raise funds through the Kings College London charity (project MEN3936) to complete the work of Professor Hermon-Taylor on the MAP Diagnostic Test. The MAP Diagnostic Test is a key tool essential for conducting a clinical trial of the Crohn’s MAP Vaccine

About the charity

King's College London

Verified by JustGiving

RCN Exempt Charities Act 1993
King's College London is one of the world's top 25 universities. It conducts world-changing research in a variety of areas including: cancer, stroke, Alzheimer's, conflict resolution and the environment. It also educates nearly 20,000 students, inspiring them to become the next generation of leaders, both in the UK and overseas. Only one third of the College's income comes from the Government - charitable donations are vital to its work. King's College London has charitable status under the Charities Act 1993.

Donation summary

Total raised
£125.00
+ £25.00 Gift Aid
Online donations
£125.00
Offline donations
£0.00

* Charities pay a small fee for our service. Find out how much it is and what we do for it.